A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
54.16% ↑
NAV (₹) on 02 Apr 2026
21.49
1 Day NAV Change
-0.88%
Risk Level
Very High Risk
Rating
-
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Aditya Birla Sun Life AMC Limited. Launched on 20 Jun 2019, investors can ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
20 Jun 2019
Min. Lumpsum Amount
₹ 500
Fund Age
6 Yrs
AUM
₹ 854.04 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.02%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 854.04 Cr
Equity
196.39%
Money Market & Cash
3.74%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 75.37% |
| Hospitals & Medical Services | 19.90% |
| Treps/Reverse Repo | 1.57% |
| Chemicals - Speciality | 1.24% |
| Insurance Distributor | 1.14% |
| Chemicals - Organic - Benzene Based | 0.81% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 13.34% | ₹ 113.96 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 7.78% | ₹ 66.43 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Limited | 5.20% | ₹ 44.39 | Pharmaceuticals |
| J.B. Chemicals & Pharmaceuticals Limited | 4.99% | ₹ 42.61 | Pharmaceuticals |
| Ajanta Pharmaceuticals Limited | 4.53% | ₹ 38.71 | Pharmaceuticals |
| Lupin Limited | 4.21% | ₹ 35.96 | Pharmaceuticals |
| Fortis Healthcare Limited | 4.17% | ₹ 35.59 | Hospitals & Medical Services |
| Aurobindo Pharma Limited | 4.16% | ₹ 35.54 | Pharmaceuticals |
| Abbott India Limited | 4.02% | ₹ 34.31 | Pharmaceuticals |
| IPCA Laboratories Limited | 3.94% | ₹ 33.67 | Pharmaceuticals |
| Cipla Limited | 3.59% | ₹ 30.62 | Pharmaceuticals |
| Emcure Pharmaceuticals Ltd | 3.03% | ₹ 25.87 | Pharmaceuticals |
| Mankind Pharma Ltd | 2.65% | ₹ 22.61 | Pharmaceuticals |
| Alkem Laboratories Limited | 2.31% | ₹ 19.76 | Pharmaceuticals |
| Shilpa Medicare Ltd | 2.20% | ₹ 18.75 | Pharmaceuticals |
| CORONA Remedies Ltd | 2.17% | ₹ 18.57 | Pharmaceuticals |
| SAI Life Sciences Ltd | 2.16% | ₹ 18.47 | Pharmaceuticals |
| Divi's Laboratories Limited | 1.95% | ₹ 16.66 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd | 1.94% | ₹ 16.58 | Hospitals & Medical Services |
| Thyrocare Technologies Limited | 1.63% | ₹ 13.96 | Hospitals & Medical Services |
| Clearing Corporation of India Limited | 1.57% | ₹ 13.39 | Others |
| METROPOLIS HEALTHCARE LIMITED | 1.50% | ₹ 12.79 | Hospitals & Medical Services |
| Dr. Reddys Laboratories Limited | 1.49% | ₹ 12.73 | Pharmaceuticals |
| Procter & Gamble Health Limited | 1.46% | ₹ 12.50 | Pharmaceuticals |
| ALEMBIC PHARMACEUTICALS LIMITED | 1.34% | ₹ 11.45 | Pharmaceuticals |
| Biocon Limited | 1.24% | ₹ 10.59 | Pharmaceuticals |
| SANOFI CONSUMER HEALTHCARE | 1.24% | ₹ 10.57 | Chemicals - Speciality |
| Jubilant Pharmova Ltd | 1.19% | ₹ 10.13 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd | 1.14% | ₹ 9.69 | Insurance Distributor |
| Pfizer Limited | 1.08% | ₹ 9.19 | Pharmaceuticals |
| Gland Pharma Limited | 1.07% | ₹ 9.11 | Pharmaceuticals |
| Suraksha Diagnostic Ltd | 1.06% | ₹ 9.09 | Hospitals & Medical Services |
| Piramal Pharma Ltd | 1.06% | ₹ 9.02 | Pharmaceuticals |
| GlaxoSmithKline Pharmaceuticals Limited | 0.99% | ₹ 8.43 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 0.92% | ₹ 7.86 | Hospitals & Medical Services |
| Max Healthcare Institute Limited | 0.90% | ₹ 7.64 | Hospitals & Medical Services |
| Vinati Organics Limited | 0.81% | ₹ 6.95 | Chemicals - Organic - Benzene Based |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -7.69% | -2.18% | 0.23% | 15.52% |
| Category returns | -7.38% | 1.10% | 4.40% | 20.04% |
Fund Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
AMC Details
Name
Aditya Birla Sun Life AMC Limited
Date of Incorporation
23 Dec 1994
CEO
Mr. A Balasubramanian
CIO
Type
Pvt.Sector-Joint Venture (Indian)
Address
One World Center, Tower 1, 17th Floor,
Jupiter Mills,
Senapati Bapat Marg,
Elphinstone Road, Mumbai, Maharashtra, India - 400013
Website
https://mutualfund.adityabirlacapital.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹110.58 | -6.78% | 32.14% | 68.19% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹110.58 | -6.78% | 32.14% | 68.19% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹183.63 | -6.78% | 32.14% | 68.18% | ₹4,273 | 1.92% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹14.90 | 4.00% | 31.81% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹14.90 | 4.00% | 31.81% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
DSP Quant Fund - Direct Plan
Largecap
Direct
|
₹20.71 | -0.11% | 31.80% | 44.78% | ₹838 | 0.55% |
Very High
|
|
HSBC Infrastructure Fund
Sector
Regular
|
₹31.33 | -7.57% | 31.57% | 70.85% | ₹2,300 | 2.06% |
Very High
|
Top Funds from Aditya Birla Sun Life AMC Limited
FAQs
What is the current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment?
The current Net Asset Value (NAV) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹21.49 as of 02 Apr 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment?
The Assets Under Management (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹854.04 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment?
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment has delivered returns of -2.18% (1 Year), 15.52% (3 Year), 6.97% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment?
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment?
The minimum lumpsum investment required for Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹500. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
The Best Way To Build A Mutual Fund Portfolio In Your 20s, 30s And 40s -
How To Gift Mutual Funds To Children: Rules, Tax Implications And Process Explained -
How to Position Portfolio Amid Global Tensions, Rising Gold,Silver ETF Inflows? Navi CEO Aditya Mulki Explains -
NPS vs Mutual Funds For Retirement: Which Investment Option Offers Better Growth, Tax Benefits And Stability? -
Big Shake-Up in Mutual Funds! SEBI Scraps Solution Funds, Introduces Life-Cycle Category | 5 Changes Explained -
Selling Mutual Funds? Here’s How You Can Save Capital Gains Tax Under Section 54F -
What Are Multi-Cap Mutual Funds? Single Fund Exposure to Large, Mid and Small-Cap Stocks; Know Details -
Can UAE-Based NRIs Invest In Indian Mutual Funds? Rules, Taxes And DTAA Explained -
What Is A Balanced Advantage Fund (BAF) And How Does It Work? -
Are Retirement Mutual Funds The Right Choice For Long-Term Investment Planning?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+